is oral semaglutide better than injectable Weekly GLP-1 Injection vs Daily Oral: and Tirzepatide – PlexusDx Injectable vs Oral Semaglutide: The

They're like, oh, no, Eli Lilly

Plasma trimethylamine n-oxide and risk of cardiovascular events in patients with type 2 diabetes

Tirzepatide is a dual GLP-1/GIP receptor agonist that has shown even greater weight loss in clinical trialsaveraging 22.5% of body weight over 72 weeks

Muscles rely on glucose for energy, so if there isnt enough, they might not work properly and could cramp up

In liver diseases such as acute hepatitis, live cirrhosis and liver cancer, elevated B12 values are often found because the liver is no longer capable of storing vitamin B12

Lillys Mounjaro (tirzepatide), a GIP/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 diabetes and heart disease 2025 [Press release]